| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 09/06/2002 | WO2002067850A2 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 09/06/2002 | WO2001095937A3 Phytoestrogenic isoflavone compositions |
| 09/06/2002 | CA2617004A1 Noninvasive measurements of chemical substances |
| 09/05/2002 | US20020123746 Process for stimulating hair growth |
| 09/05/2002 | US20020123532 E.g., bis(3,5-dibromo-2,4,6-trihydroxyphenyl)squaraine and bis(3,5- diiodo-2,4,6-trihydroxyphenyl)squaraine; anticarcinogenic and-tumor agents; fluorescent detector of tumors; sterilization of water; stability; nontoxic |
| 09/05/2002 | US20020123531 Purging malignant cells from a mixture with nonmalignant cells by radiating the dye to photoactivate it; elimination of residual tumor cells from autologous bone marrow grafts with minimum toxicity toward normal cells |
| 09/05/2002 | US20020123530 Use of crystal violet as photochemotherapeutic agent |
| 09/05/2002 | US20020123032 Detection of disease related genes |
| 09/05/2002 | US20020122805 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell. |
| 09/05/2002 | US20020122236 Methods and apparatus for optical imaging |
| 09/05/2002 | DE10104761A1 Method for modifying essence for use in Bach blood therapy to suit particular organism comprises taking Kirlian photograph of essence and then projecting this through essence |
| 09/04/2002 | EP1236465A2 Use of legume products for the treatment of external aggressions |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | CN1367029A Therapeutic patch |
| 09/04/2002 | CN1090022C Cancer treatment by photodynamic therapy, in combination with immunoadjuvant |
| 09/04/2002 | CN1090021C Preparation method and use of sulfated oligosaccharides |
| 09/03/2002 | US6444660 Dexamethasone covalently bonded to a lipid moiety via a linking group |
| 09/03/2002 | US6444233 Triterpene compositions and methods for use thereof |
| 09/03/2002 | US6443976 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 09/03/2002 | US6443898 Therapeutic delivery systems |
| 09/03/2002 | US6443882 Apparatus and method for creating a biologically useful magnetic field |
| 09/03/2002 | CA2096841C Drug delivery porphyrin compositions and methods |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066060A2 Method and device for ultrasound-assisted transmembrane medicament application in vitro |
| 08/29/2002 | WO2002066044A2 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 08/29/2002 | WO2002065992A2 A cell therapy method for the treatment of tumors |
| 08/29/2002 | WO2001080888A3 Method for treatment of tumors using photodynamic therapy |
| 08/29/2002 | US20020120008 Life extension of drosophila by a drug treatment |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438754A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2426659A1 Method for treatment of tumors using combination therapy |
| 08/27/2002 | US6441025 Water soluble paclitaxel derivatives |
| 08/27/2002 | US6440950 Selective and non-invasive visualization or treatment of vasculature |
| 08/27/2002 | US6439236 Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles |
| 08/22/2002 | WO2002064163A2 Reduction or prevention of pdt related inflammation |
| 08/22/2002 | WO2001091794A3 Vitamin d3 analogs as radiosensitizers for the treatment of cancer |
| 08/22/2002 | US20020115649 Use of texaphyrins in macrophage-mediated disease |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/22/2002 | US20020114793 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 08/22/2002 | DE10106550A1 BSE-Test und BSE.Schnell-Test Erfindung der BSE.Gegen-Medizin (Heilmittel)und Einschlägige Grundlagen des Schrift-Inhalts BSE testing and test BSE.Schnell invention of BSE.Gegen medicine (medicine) and Relevant basics of writing content |
| 08/15/2002 | WO2002062985A1 A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof |
| 08/15/2002 | WO2002062983A1 A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof |
| 08/15/2002 | WO2002062981A1 A yeast human immunoregulator and the method for preparing it |
| 08/15/2002 | WO2002062806A1 Organofunctionalized per-b-hydroxy polyhedral boranes |
| 08/15/2002 | WO2002062397A2 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens |
| 08/15/2002 | WO2002062386A2 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration |
| 08/15/2002 | WO2002062385A2 Method to prevent vision loss |
| 08/15/2002 | WO2002062384A2 Reduced fluence rate pdt |
| 08/15/2002 | WO2002062350A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | WO2002004023A3 Photoactivated drug therapy |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110549 Presbyopia treatment by lens alteration |
| 08/15/2002 | CA2437561A1 Use of additional photodynamic therapy in the treatment of choroidal neovasculature |
| 08/15/2002 | CA2437087A1 Methods for the administration of amifostine and related compounds |
| 08/14/2002 | EP1229942A1 Method and formula for tumor remission and suppression of cancer |
| 08/14/2002 | EP1229937A2 Use of pdt to inhibit intimal hyperplasia |
| 08/14/2002 | EP1229935A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 08/14/2002 | EP1229867A2 Ophthalmologic implant |
| 08/14/2002 | EP0697876B1 Xenograft thymus |
| 08/13/2002 | US6433343 Device and method for photoactivation |
| 08/13/2002 | US6432399 Treatment of stress and preconditioning against stress |
| 08/12/2002 | WO2001034196A2 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2398832A1 Mixture containing rare earths and use thereof |
| 08/08/2002 | WO2002060483A2 Perylenequinones for use as photosensitizers and sonosensitizers |
| 08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
| 08/08/2002 | WO2002060461A1 Blood brain barrier modulation using stressed autologous blood cells |
| 08/08/2002 | WO2002060416A1 Polypeptide delivery system and method for their preparation |
| 08/08/2002 | WO2002060383A2 Cancer therapy |
| 08/08/2002 | WO2001095944A3 Photocleavable prodrugs for selective drug delivery |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001085212A3 Drug delivery systems for photodynamic therapy |
| 08/08/2002 | US20020108129 Method for producing anterior ischemic optic neuropathy in animals |
| 08/08/2002 | US20020107281 Applying a phototherapeutic modality to produce an acute, necrotic effect on a treated tumor without completely denaturing tumor antigens present in said tumor; especially enhanced with a halogenated xanthene |
| 08/08/2002 | US20020106327 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 08/08/2002 | DE10107575A1 Verfahren zur Fett-und Gewichtsreduktion im menschlichen oder tierischen Organismus durch Nutzung des photodynamischen Effekts A method for fat and weight loss in the human or animal body by use of photodynamic effect |
| 08/08/2002 | CA2436343A1 Blood brain barrier modulation using stressed autologous blood cells |
| 08/08/2002 | CA2436245A1 Medicament for protection in radiotherapy |
| 08/07/2002 | EP1228755A1 Use of biodegradable microspheres for the delivery of an anticancer agent for the treatment of gliblastoma |
| 08/07/2002 | EP1227845A2 Mixture containing rare earths and use thereof |
| 08/07/2002 | EP1227844A2 Compositions for treating atheroma and neoplastic tissue |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/06/2002 | US6428811 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 08/06/2002 | CA2144327C Transcutaneous in vivo activation of photosensitive agents in blood |
| 08/01/2002 | WO2002059277A2 Electroactive materials for stimulation of biological activity of stem cells |
| 08/01/2002 | WO2002058789A1 Ocular iontophoretic device and method of use |
| 08/01/2002 | WO2002058730A2 Compositions for treatment of ocular neovascularization |
| 08/01/2002 | WO2002024226A3 Photosensitisers |
| 08/01/2002 | WO2001085213A3 Supports for photosensitizer formulations |
| 08/01/2002 | US20020103517 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 08/01/2002 | US20020103200 1,2,4-Benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 08/01/2002 | US20020103180 Methods, compositions and articles for reducing or preventing the effects of inflammation |
| 08/01/2002 | US20020103141 DNA topoisomerase I and cyclooxygenase-2 (COX-2) inhibiting agents |
| 08/01/2002 | CA2333494A1 Blood brain barrier modulation |
| 07/31/2002 | EP1226221A1 Fluorescent film |
| 07/31/2002 | EP1225911A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 07/31/2002 | CN1361700A Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
| 07/25/2002 | WO2002057285A1 Fullerene derivative and composition comprising the same |